These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3413795)

  • 1. Reversible interaction of a reactive intermediate derived from furazolidone with glutathione and protein.
    Vroomen LH; Berghmans MC; Groten JP; Koeman JH; van Bladeren PJ
    Toxicol Appl Pharmacol; 1988 Aug; 95(1):53-60. PubMed ID: 3413795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a reactive intermediate of furazolidone formed by swine liver microsomes.
    Vroomen LH; Groten JP; van Muiswinkel K; van Velduizen A; van Bladeren PJ
    Chem Biol Interact; 1987; 64(1-2):167-79. PubMed ID: 3690722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiophene sulfoxides as reactive metabolites: formation upon microsomal oxidation of a 3-aroylthiophene and fate in the presence of nucleophiles in vitro and in vivo.
    Valadon P; Dansette PM; Girault JP; Amar C; Mansuy D
    Chem Res Toxicol; 1996 Dec; 9(8):1403-13. PubMed ID: 8951246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The elimination of furazolidone and its open-chain cyano-derivative from adult swine.
    Vroomen LH; Berghmans MC; Hekman P; Hoogenboom LA; Kuiper HA
    Xenobiotica; 1987 Dec; 17(12):1427-35. PubMed ID: 3326298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative studies of the metabolism of furazolidone by rat liver microsomes.
    Vroomen LH; van Ommen B; van Bladeren PJ
    Toxicol In Vitro; 1987; 1(2):97-104. PubMed ID: 20647073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The residue behavior of the furazolidone metabolite 3-(4-cyano-2-oxobutylideneamino)-2-oxazolidone in trout].
    Wölwer-Rieck U; Büning-Pfaue H
    Z Lebensm Unters Forsch; 1990; 191(4-5):319-21. PubMed ID: 2293521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic and pulmonary microsomal metabolism of naphthalene to glutathione adducts: factors affecting the relative rates of conjugate formation.
    Buckpitt AR; Bahnson LS; Franklin RB
    J Pharmacol Exp Ther; 1984 Nov; 231(2):291-300. PubMed ID: 6491983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fate and microbiological effects of furazolidone in a marine aquaculture sediment.
    Samuelsen OB; Solheim E; Lunestad BT
    Sci Total Environ; 1991 Oct; 108(3):275-83. PubMed ID: 1754880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study on the role of glutathione in the biotransformation and toxicity of furazolidone using pig hepatocytes.
    Hoogenboom LA; van Kammen M; Huveneers-Oorsprong MB; Kuiper HA
    Toxicol In Vitro; 1992 May; 6(3):227-37. PubMed ID: 20732118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reductive metabolism of furazolidone by Escherichia coli and rat liver in vitro.
    Abraham RT; Knapp JE; Minnigh MB; Wong LK; Zemaitis MA; Alvin JD
    Drug Metab Dispos; 1984; 12(6):732-41. PubMed ID: 6150823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of in vivo potential for metabolic activation of drugs into chemically reactive intermediate: correlation of in vitro and in vivo generation of reactive intermediates and in vitro glutathione conjugate formation in rats and humans.
    Masubuchi N; Makino C; Murayama N
    Chem Res Toxicol; 2007 Mar; 20(3):455-64. PubMed ID: 17309281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The in vitro formation of glutathione conjugates with the microsomally activated pulmonary bronchiolar aklylating agent and cytotoxin, 4-ipomeanol.
    Buckpitt AR; Boyd MR
    J Pharmacol Exp Ther; 1980 Oct; 215(1):97-103. PubMed ID: 7452496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of pig hepatocytes to study the nature of protein-bound metabolites of furazolidone: a new analytical method for their detection.
    Hoogenboom LA; van Kammen M; Berghmans MC; Koeman JH; Kuiper HA
    Food Chem Toxicol; 1991 May; 29(5):321-8. PubMed ID: 2060890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism in vivo of furazolidone: evidence for formation of an open-chain carboxylic acid and alpha-ketoglutaric acid from the nitrofuran in rats.
    Tatsumi K; Nakabeppu H; Takahashi Y; Kitamura S
    Arch Biochem Biophys; 1984 Oct; 234(1):112-6. PubMed ID: 6486813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biotransformation of furaltadone by pig hepatocytes and Salmonella typhimurium TA 100 bacteria, and the formation of protein-bound metabolites.
    Hoogenboom LA; Polman TH; Lommen A; Huveneers MB; van Rhijn J
    Xenobiotica; 1994 Aug; 24(8):713-27. PubMed ID: 7839695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of short-term tests for mutagenicity: on the optimal pH for the liver microsomal assay.
    Paolini M; Sapigni E; Hrelia P; Grilli S; Lattanzi G; Cantelli-Forti G
    Carcinogenesis; 1988 Dec; 9(12):2265-70. PubMed ID: 3191571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cresol isomers: comparison of toxic potency in rat liver slices.
    Thompson DC; Perera K; Fisher R; Brendel K
    Toxicol Appl Pharmacol; 1994 Mar; 125(1):51-8. PubMed ID: 8128495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irreversible protein binding of acrylonitrile.
    Peter H; Bolt HM
    Xenobiotica; 1981 Jan; 11(1):51-6. PubMed ID: 6261465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some factors determining the concentration of liver proteins for optimal mutagenicity of chemicals in the Salmonella/microsome assay.
    Malaveille C; Kuroki T; Brun G; Hautefeuille A; Camus AM; Bartsch H
    Mutat Res; 1979 Dec; 63(2):245-58. PubMed ID: 392308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formation of glutathione conjugates by reactive metabolites of vinylidene chloride in microsomes and isolated hepatocytes.
    Liebler DC; Meredith MJ; Guengerich FP
    Cancer Res; 1985 Jan; 45(1):186-93. PubMed ID: 3965130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.